Diagnostic Imaging

NOVEMBER 13, 2023

Experts highlight gallium-based and PyL PSMA-PET scans for use in prostate cancer, commenting on approvals as well as how the agents are made.

PET Scan 52

PET Scan 52

TRA Medical Imaging

NOVEMBER 29, 2024

In addition to PSMA PET, we offer theranostic treatment options for patients with PSMA-positive prostate cancer, combining targeted therapy with diagnostic imaging for a personalized approach to treatment. Fast, Local, and Convenient Care We understand the importance of timely results for your peace of mind.

Imaging 59

Imaging Medical Imaging PET Scan Disease 59

Diagnostic Imaging

NOVEMBER 13, 2023

Radiology experts discuss the current knowledge and use of PSMA-PET screening among colleagues, as well as unmet needs.

PET Scan 83

PET Scan Radiology 83

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 Gauden , D.Phil., 18F-rhPSMA-7.3

Diagnostic 98

Diagnostic Radiopharmaceuticals Imaging Radiation 98

Diagnostic Imaging

JANUARY 25, 2024

For patients with recurrent prostate cancer, PET scanning with 18F-flotufolastat led to major changes in treatment for 80 percent of patients and 75 percent of patients with a changed treatment focus to watchful waiting had negative scans, according to new research presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (..)

PET Scan 91

PET Scan Imaging Clinic 91

Associates in Medical Imaging

FEBRUARY 15, 2021

As technological capabilities advance across all medical disciplines, so to do the imaging needs that often come with adequate diagnostic capabilities. Doctors can use MRI to get highly refined, detailed scans of the human body's interior portions without needing to perform any form of surgical intervention for diagnostic purposes.

Magnetic Resonance Imaging 52

Magnetic Resonance Imaging Imaging Modalities Diagnostic MRI 52

Diagnostic Imaging

MAY 30, 2023

Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum (..)

PET Scan 86

PET Scan Imaging 86

Diagnostic Imaging

JULY 19, 2023

Recognizing the advent of beta amyloid-targeted therapies for the treatment of Alzheimer’s disease, the Centers for Medicare and Medicaid (CMS) has proposed eliminating coverage restrictions that limit amyloid positron emission tomography (PET) scans to clinical trial participants and one amyloid PET scan per lifetime.

Disease 52

Disease PET Scan Medicare Imaging 52

Open Medscience

AUGUST 18, 2024

Diagnostic imaging in motor neurone disease (MND) is crucial for early detection, disease monitoring, and differentiating from other conditions. The post Motor Neurone Disease: Diagnosis and Future Research Insights appeared first on Open MedScience.

Disease 52

Disease Diagnostic Imaging Diagnostic Imaging 52

TRA Medical Imaging

NOVEMBER 29, 2024

In addition to PSMA PET, we offer theranostic treatment options for patients with PSMA-positive prostate cancer, combining targeted therapy with diagnostic imaging for a personalized approach to treatment. Fast, Local, and Convenient Care We understand the importance of timely results for your peace of mind.

Imaging 52

Imaging Medical Imaging PET Scan Disease 52

Independent Imaging

APRIL 24, 2020

Diagnostic imaging plays a very important role in modern medicine. A CT (computerized tomography) scan is used to enable doctors to see clear images of the structures and tissues of your body. This type of scan may be ordered for a number of reasons, from detecting a joint problem to assessing a tumor for changes.

X-ray 52

X-ray Diagnostic Imaging Radiologist Imaging 52

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

AuntMinnie

JULY 1, 2024

"F-18 PSMA-1007 PET/CT provided improved accuracy compared with multiparametric MRI for prostate cancer tumor staging before radical treatment," the group wrote. The diagnosis and management of intermediate-risk and high-risk prostate cancer are increasingly informed by advances in diagnostic imaging, the authors noted.

MRI 264

MRI PET Scan Nuclear Medicine Bone Scan 264

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130